Baseline characteristic | N=36 (intent to treat) |
---|---|
Age (years) | 70.6±8.5 |
Gender (% male) | 24/36 (67%) |
Ischaemic cardiomyopathy (%) | 21/36 (58%) |
Diabetes (%) | 11/36 (31%) |
Hypertension (%) | 25/36 (69%) |
CRT eligible (%) | 9/36 (25)% |
NYHA class | II—5.6% |
III—88.8% | |
IV—5.6% | |
History of atrial fibrillation (%) | 17/36 (47)% |
6 min walk test (m) | 287.9±87 |
LVEF (%) | 34.0±10.1 |
LVEDD (mm) | 62.3±8.2 |
MR grade (%) | 2+−28% |
3+−61% | |
4+−11% | |
Creatinine (mg/dL) | 1.4±0.9 |
Haematocrit (mg/dL) | 40.0±4.9 |
LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; NYHA, New York Heart Association.